Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› København Ø
Clinical trial register · Denmark

Clinical Trials in København Ø, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Copenhagen 974 Aarhus 586 Odense 441 Aalborg 384 Herlev 314
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hoffmann-La Roche19 AstraZeneca9 Copenhagen University Hospital, Rigshospitalet4 Boehringer Ingelheim4 Novo Nordisk A/S4
Site location
Copenhagen974 Aarhus586 Odense441 Aalborg384 Herlev314
All 128 locations
Target enrolment
to

Trials with a site in København Ø

60 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Not yet open
AstraZeneca
Phase 3
750
Aarhus, København Ø, Odense
2026-08-25
Recruiting
Hoffmann-La Roche
Phase 3
380
Aarhus, København Ø, Vejle
2026-06-23
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Aabenraa, Frederiksberg, Herlev, Hjørring, Holbæk, Hvidovre, København Ø, Svendborg
2026-05-11
Recruiting
Hoffmann-La Roche
Phase 3
360
København Ø
2026-04-27
Recruiting
GlaxoSmithKline
Phase 1
97
København Ø
2026-03-23
Recruiting
Boehringer Ingelheim
Phase 3
286
København Ø, Roskilde
2026-02-16
Recruiting
Novo Nordisk A/S
Phase 3
332
Gistrup, København Ø
2025-12-18
Recruiting
AstraZeneca
Phase 2
230
Aarhus N, Gistrup, Hvidovre, København Ø, Odense C
2025-12-10
Recruiting
Zealand University Hospital
Observational
2,500
Aarhus N, Herlev, København Ø, Roskilde
2025-11-26
By invitation
Optical Coherence Tomography in Acute Vessel Evaluation
NCT07422688Ischemic Heart Disease, Ischemic Coronary Artery Disease, ACS (Acute Coronary Syndrome)
Aarhus University Hospital Skejby
Not applicable
3,000
Aalborg, Aarhus N, København Ø, Odense, Roskilde
2025-11-23
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Aalborg, Aarhus N, København Ø
2025-11-12
Recruiting
Hoffmann-La Roche
Phase 3
600
Køge, Aarhus N, Herlev, København Ø, Sønderborg
2025-10-24
Recruiting
GlaxoSmithKline
Phase 1/2
47
København Ø
2025-10-20
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Aalborg, Aarhus N, København Ø
2025-07-02
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Aarhus N, København Ø, Odense C
2025-07-02
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Aalborg, Aarhus N, Hvidovre, København Ø, Vejle
2025-06-09
Recruiting
Copenhagen University Hospital, Rigshospitalet
Observational
90
København Ø
2025-05-14
Recruiting
Hoffmann-La Roche
Phase 1
405
København Ø
2025-04-30
Recruiting
Takeda
Observational
30
Aarhus N, København Ø
2025-04-29
Active, closed
Hoffmann-La Roche
Phase 2
30
København Ø
2025-04-04
Recruiting
AstraZeneca
Phase 3
600
Aalborg, Herlev, København Ø, Odense
2025-03-27
Recruiting
GlaxoSmithKline
Phase 1/2
305
København Ø, Herlev
2025-03-04
Active, closed
Boehringer Ingelheim
Phase 2
90
København Ø
2024-12-30
By invitation
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT06679946Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
DrugVutrisiran
Alnylam Pharmaceuticals
Phase 3
700
Aarhus N, København Ø, Odense C
2024-12-03
Recruiting
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
NCT07263490Pre-eclampsia, Oocyte Donation, Pre-Eclampsia; Complicating Pregnancy, Pre-Eclampsia; Mild
Copenhagen University Hospital, Hvidovre
Observational
462
Copenhagen, Hellerup, Herlev, København S, København Ø, Søborg
2024-10-21
Recruiting
AstraZeneca
Phase 1/2
174
København Ø
2024-09-18
Active, closed
Hoffmann-La Roche
Phase 1
34
København Ø
2024-09-16
Recruiting
Copenhagen University Hospital, Rigshospitalet
Not applicable
590
København Ø
2024-08-01
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Hellerup, Aalborg, Aarhus N, Gistrup, Hillerød, København Ø, Odense C, Svendborg
2024-06-25
Recruiting
Vividion Therapeutics, Inc.
Phase 1
280
København Ø
2024-01-25
Recruiting
AstraZeneca
Phase 3
800
Aarhus N, København Ø, Odense
2023-09-22
Active, closed
Boehringer Ingelheim
Phase 2
268
Aalborg, Hvidovre, København Ø, Odense, Roskilde, Vejle
2023-09-08
Recruiting
Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Ischemia
NCT05244629Mesenteric Ischemia, Bowel; Ischemic, Superior Mesenteric Atherosclerosis, Mesenteric Artery Stenosis
Copenhagen University Hospital, Rigshospitalet
Not applicable
98
København Ø
2023-06
Active, closed
Bayer
Phase 3
985
Aarhus N, Aalborg, Næstved, København Ø
2023-04-03
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
København Ø
2023-02-13
Active, closed
Hoffmann-La Roche
Phase 2
301
København Ø
2023-02-03
Recruiting
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
NCT05574673Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Observational
1,000
København Ø
2022-12-01
Recruiting
Hoffmann-La Roche
Phase 1/2
65
København Ø
2022-11-16
Active, closed
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Phase 2
188
København Ø
2021-12-15
Active, closed
Amgen
Phase 3
303
Aalborg, Aarhus N, København Ø, Odense
2021-11-02
Recruiting
Hoffmann-La Roche
Phase 1
542
Herlev, København Ø
2021-10-22
Active, closed
Hoffmann-La Roche
Phase 1/2
42
København Ø
2021-09-14
Recruiting
Genentech, Inc.
Phase 1
186
København Ø
2021-07-26
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Aalborg, København Ø
2021-07-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
København Ø, Aarhus
2021-05-12
Active, closed
Objective Grading of MTS With LSCI and Thermography
NCT04796493Mesenteric Traction Syndrome
Copenhagen University Hospital, Rigshospitalet
Observational
98
København Ø
2021-03-16
Active, closed
Hoffmann-La Roche
Phase 3
270
Aarhus N, København Ø
2021-02-23
Active, closed
Hoffmann-La Roche
Phase 2
920
København Ø
2021-01-18
Active, closed
AstraZeneca
Phase 3
957
Aalborg, København Ø, Odense
2020-11-17
Active, closed
AstraZeneca
Phase 3
134
København Ø
2020-07-20
Active, closed
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
NCT04140500Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma
DrugTobemstomig
Hoffmann-La Roche
Phase 1/2
170
København Ø, Odense C
2019-11-11
Active, closed
Hoffmann-La Roche
Phase 1/2
498
Aarhus N, København Ø, Odense C
2019-08-13
Active, closed
Hoffmann-La Roche
Phase 3
1,000
København Ø
2019-02-28
Active, closed
AstraZeneca
Phase 2
367
Aalborg, Herlev, København Ø, Næstved, Odense, Vejle
2019-01-09
Active, closed
Hoffmann-La Roche
Phase 1/2
211
Aarhus N, København Ø, Odense C
2018-05-08
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Aalborg, Aarhus, Esbjerg, København Ø, Odense
2017-09-12
Active, closed
Eli Lilly and Company
Phase 3
5,637
Copenhagen, København Ø, Aarhus, Herning, Aalborg, Næstved, Esbjerg, Odense
2017-07-12
Active, closed
Aarhus University Hospital Skejby
Not applicable
1,201
Aalborg, Aarhus N, Gentofte Municipality, København Ø, Odense, Roskilde
2017-07-05
Active, closed
Hoffmann-La Roche
Phase 1/2
940
København Ø
2017-02-21
Active, closed
AstraZeneca
Phase 3
1,126
Århus C, Herlev, København Ø, Odense C
2015-11-02
Rows per page Showing 1–60 of 60
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/k-benhavn

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 60 of those studies with a site in København Ø.

How many clinical trials are recruiting in København Ø?

30 of the 60 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 27 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (København Ø), 60 studies
PhaseStudiesRecruitingShare
Phase 3261243.3%
Phase 1/29415%
Phase 28113.3%
Observational7611.7%
Phase 16510%
Not applicable426.7%

Most active sponsors

Lead sponsors with the most studies (København Ø)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche197
AstraZeneca94
Boehringer Ingelheim42
Copenhagen University Hospital, Rigshospitalet43
Novo Nordisk A/S42
GlaxoSmithKline33
Aarhus University Hospital Skejby20
Alnylam Pharmaceuticals21
Nordic Society of Gynaecological Oncology - Clinical Trials Unit21
Amgen10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.